AgeX Therapeutics Inc. (was merged with Biotechnology Serina Therapeutics (NYSE: SER) on 27/04/2024) (AGE)
New Form 8-K - Serina Therapeutics, Inc. Filed: 2025-07-29 AccNo: 0001708599-25-000076 Size: 3 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
There are no comments here yet...